Menu
Director's Message and Videos

Director's Message and Videos

Welcome to our web site. Thr...

Take a look

Take a look

Scientific and Technical Ser...

Personnel

Personnel

  Personnel List

Jobs

Jobs

Available Positions

Prev Next
Epitaxial ferromagnetic oxide thin films on silicon with atomically sharp interfaces

Epitaxial ferromagnetic oxide thin films on silicon with atomically sharp interfaces

P. de Coux, R. Bachelet, B. Warot-Fonrose, V. Skumryev, L. Lupina, G. Niu, T. Schroeder, J. Fontcuberta and F. Sánchez. Appl. Phys. Lett. 105, 012401 (2014)

NANOMOL is partner of a project against Chagas disease

  • Hits: 4706

The Vall the Hebron Research Institute (VHIR) leads an international Project for the development of a more effective and cheaper drug, for the treatment of Chagas disease that also helps to reduce the number of undesirable side effect of actual therapies

. Coordinated by Dr. Israel Molina, one of the maximum world experts in Chagas and member of the infectious diseases research group of VHIR, the project BERENICE is financed by the 7th framework program of the European Commission. The 4 years project counts with the participation of prestigious European and South-American entities.

The project BERENICE, acronym of BEnznidazol and triazol Research group for Nanomedicine and Innovation on Chagas disease (Benznidazol and triazol research group for the nanomedicine and innovation in Chagas disease), will reformulate a existing drug, the Benznidazol, for the obtaining of a safer toxicity profile and to increment its efficacy. The design of the new nano- or micro- encapsulated formulation will be developed by CIBBER-BBN, in which are integrated the research groups NANOMOL-CSIC (ICMAB) and NANOBIOCEL from the University of Basque Country.

MORE INFORMATION

Organisation

Sc.&Technical Services

Scientific Highlights

Links of interest

pie2014

sts banner

logoeugris    mecgris    csicgris
bncbgris          uabgris        uabceigris      pruabgris